Hangzhou Diagens Biotechnology Co (HKSE:02526) PEG Ratio: N/A (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02526 Hangzhou Diagens Biotechnology Co Ltd HKSE:02526
8 GF Score
Price HK$370.00
! 1 Warning Sign
View Full Analysis

What is Hangzhou Diagens Biotechnology Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Hangzhou Diagens Biotechnology Co's PE Ratio without NRI is 0.00. Hangzhou Diagens Biotechnology Co's 5-Year EBITDA growth rate is 0.00%. Therefore, Hangzhou Diagens Biotechnology Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Hangzhou Diagens Biotechnology Co's PEG Ratio or its related term are showing as below:



HKSE:02526's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.075
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.

Hangzhou Diagens Biotechnology Co  (HKSE:02526) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

Hangzhou Diagens Biotechnology Co PEG Ratio Related Terms

Hangzhou Diagens Biotechnology Co PEG Ratio Historical Data

* Premium members only.

The historical data trend for Hangzhou Diagens Biotechnology Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Diagens Biotechnology Co PEG Ratio Chart

Hangzhou Diagens Biotechnology Co Annual Data
Trend Dec23 Dec24 Dec25
PEG Ratio
0.00 0.00 0.00

Hangzhou Diagens Biotechnology Co Quarterly Data
Dec23 Dec24 Sep25 Dec25 Jun26
PEG Ratio 0.00 0.00 0.00 0.00 0.00

HKSE:02526 vs ABT, SYK, MDT: PEG Ratio Comparison

For the Medical Devices subindustry, Hangzhou Diagens Biotechnology Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Diagens Biotechnology Co PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou Diagens Biotechnology Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Hangzhou Diagens Biotechnology Co's PEG Ratio falls into.


HKSE:02526
8GF Score
Hangzhou Diagens Biotechnology Co Ltd HKSE:02526
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Diagens Biotechnology Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Hangzhou Diagens Biotechnology Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Hangzhou Diagens Biotechnology Co Business Description

Address No. 609 Hongfeng Road, Room 101, Building 1, Donghu Sub-district, Linping District, Zhejiang, Hangzhou, CHN
Hangzhou Diagens Biotechnology Co Ltd and its subsidiaries are involved in the development and commercialisation of medical imaging artificial intelligence technologies and medical imaging equipment. It has self-developed a diversified portfolio, including six medical imaging software products, three commercialized medical devices, four key reagents and consumables and two technology licensing offerings. Its Core Product, AI AutoVision, is an auxiliary diagnostic software designed to undertake intelligent analysis on chromosome karyotyping. The majority of the company's revenue is derived from Technology Licensing, mainly in the Chinese mainland.
8GF Score

Get the complete analysis for HKSE:02526

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$370.00
Price